DOMH
Price
$1.94
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
29 days until earnings call
MDGL
Price
$215.60
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
20 days until earnings call
Ad is loading...

DOMH vs MDGL

Header iconDOMH vs MDGL Comparison
Open Charts DOMH vs MDGLBanner chart's image
Dominari Holdings
Price$1.94
Change-$0.00 (-0.00%)
Volume$32.79K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$215.60
Change-$0.00 (-0.00%)
Volume$240.62K
CapitalizationN/A
View a ticker or compare two or three
DOMH vs MDGL Comparison Chart
Loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DOMH vs. MDGL commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOMH is a Hold and MDGL is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (DOMH: $1.94 vs. MDGL: $215.60)
Brand notoriety: DOMH and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOMH: 293% vs. MDGL: 87%
Market capitalization -- DOMH: $11.92M vs. MDGL: $4.61B
DOMH [@Biotechnology] is valued at $11.92M. MDGL’s [@Biotechnology] market capitalization is $4.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOMH’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • DOMH’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than DOMH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOMH’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 6 bullish TA indicator(s).

  • DOMH’s TA Score: 5 bullish, 3 bearish.
  • MDGL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than DOMH.

Price Growth

DOMH (@Biotechnology) experienced а +2.65% price change this week, while MDGL (@Biotechnology) price change was +2.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

DOMH is expected to report earnings on Nov 15, 2024.

MDGL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($4.61B) has a higher market cap than DOMH($11.9M). MDGL YTD gains are higher at: -6.820 vs. DOMH (-25.097). DOMH has higher annual earnings (EBITDA): -14.02M vs. MDGL (-494.77M). MDGL has more cash in the bank: 1.06B vs. DOMH (12.1M). DOMH has less debt than MDGL: DOMH (3.24M) vs MDGL (118M). MDGL has higher revenues than DOMH: MDGL (14.6M) vs DOMH (9.51M).
DOMHMDGLDOMH / MDGL
Capitalization11.9M4.61B0%
EBITDA-14.02M-494.77M3%
Gain YTD-25.097-6.820368%
P/E RatioN/AN/A-
Revenue9.51M14.6M65%
Total Cash12.1M1.06B1%
Total Debt3.24M118M3%
FUNDAMENTALS RATINGS
DOMH vs MDGL: Fundamental Ratings
DOMH
MDGL
OUTLOOK RATING
1..100
753
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
7860
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DOMH's Valuation (11) in the null industry is somewhat better than the same rating for MDGL (72) in the Pharmaceuticals Other industry. This means that DOMH’s stock grew somewhat faster than MDGL’s over the last 12 months.

MDGL's Profit vs Risk Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for DOMH (100) in the null industry. This means that MDGL’s stock grew somewhat faster than DOMH’s over the last 12 months.

DOMH's SMR Rating (96) in the null industry is in the same range as MDGL (98) in the Pharmaceuticals Other industry. This means that DOMH’s stock grew similarly to MDGL’s over the last 12 months.

MDGL's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as DOMH (78) in the null industry. This means that MDGL’s stock grew similarly to DOMH’s over the last 12 months.

MDGL's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as DOMH (100) in the null industry. This means that MDGL’s stock grew similarly to DOMH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DOMHMDGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
+6.59%
AXON - DOMH
36%
Loosely correlated
-0.07%
ACLX - DOMH
31%
Poorly correlated
+3.44%
ARDX - DOMH
31%
Poorly correlated
-2.01%
ELVN - DOMH
28%
Poorly correlated
+1.08%
MDGL - DOMH
28%
Poorly correlated
-0.26%
More